SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Laurus Labs board to consider dividend

08 May 2017 Evaluate

Laurus Labs has informed that a meeting of the Board of Directors of the Company will be held on May 18, 2017, to consider and approve the Audited Financial Results of the Company for the Financial Year ended March 31, 2017 and to recommend Dividend, if any, on Equity Shares for the year ended March 31, 2017. Further, the Company’s trading window for dealing in securities by the Directors and Designated Persons shall be closed from May 11, 2017 to May 20, 2017.

The above information is a part of company’s filings submitted to BSE.

Laurus Labs Share Price

1480.50 29.90 (2.06%)
29-Jun-2026 11:03 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1890.00
Dr. Reddys Labs. 1405.85
Cipla 1482.00
Zydus Lifesciences 1121.00
Lupin 2397.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: